GYNECOLOGIC ONCOLOGY Journal
Overview
publication venue for
- Post-surgical ctDNA-based molecular residual disease detection in patients with stage I uterine malignancies. 182:63-69. 2024
- Niraparib and dostarlimab for the treatment of recurrent platinum-resistant ovarian cancer: results of a Phase II study (MOONSTONE/GOG-3032). 178:161-169. 2023
- Clinical outcomes analysis of neoadjuvant chemotherapy for locally advanced vulvar cancer 2023
- Comparative analysis of patients with endometrial cancer managed by three surgical approaches: A long-term Bulgarian experience for peri-operative and survival outcomes 2023
- Immunotherapy response monitoring using personalized circulating tumor DNA analysis in patients with relapsed gynecologic malignancies 2023
- Post-surgical ctDNA-based molecular residual disease detection in patients with stage I endometrial cancer 2023
- Analysis of "sandwich" chemo-radiation therapy for stage IIIC endometrial cancer 2023
- Is mismatch repair status prognostic of clinical outcomes in patients with early stage endometrioid endometrial cancer? 2023
- Malignant peritoneal cytologic contamination with robotic hysterectomy for endometrial cancer. 175:93-96. 2023
- Molecular portraits of clear cell ovarian and endometrial carcinoma with comparison to clear cell renal cell carcinoma. 169:164-171. 2023
- Clinical and molecular characteristics of ARIEL3 patients who derived exceptional benefit from rucaparib maintenance treatment for high-grade ovarian carcinoma. 167:404-413. 2022
- Genomic profiling in low grade serous ovarian cancer: Identification of novel markers for disease diagnosis and therapy. 167:306-313. 2022
- A phase 1b study of intraperitoneal oncolytic viral immunotherapy in platinum-resistant or refractory ovarian cancer. 163:481-489. 2021
- Assessment of immune biomarkers and establishing a triple negative phenotype in gynecologic cancers. 163:312-319. 2021
- Neoadjuvant chemotherapy followed by fertility sparing surgery in cervical cancers size 2-4 cm; emerging data and future perspectives 2021
- FOXL2 mutation is prevalent in metastatic adult granulosa cell tumors and is associated with improved survival 2021
- Sentinel lymph node biopsy versus complete lymphadenectomy in high grade endometrial cancer: a systematic review and meta-analysis of performance characteristics 2021
- Transcriptomic immune profiling: a precision path forward for immunotherapy in patients with cervical cancer? 2021
- Sentinel lymph node (SLN) isolated tumor cells (ITCs) in otherwise stage I/II endometrioid endometrial cancer: To treat or not to treat?. 161:347-352. 2021
- Pathologic and clinical tumor size discordance in early-stage cervical cancer: Does it matter?. 159:354-358. 2020
- Phase II VIRO-15 trial of olvimulogene nanivacirepvec (Olvi-Vec)-primed immunochemotherapy in platinum-resistant/refractory ovarian cancer (PRROC) (NCT02759588) 2020
- Postprogression outcomes in patients with ovarian carcinoma associated with amutation in a non-BRCA homologous recombination repair gene receiving rucaparib maintenance treatment: Results from the phase III study ARIEL3 2020
- Robotic-assisted laparoscopic splenectomy in recurrent ovarian cancer: A case series with clinical outcomes 2020
- The effect of age on efficacy, safety and patient-centered outcomes with rucaparib: A post hoc exploratory analysis of ARIEL3, a phase 3, randomized, maintenance study in patients with recurrent ovarian carcinoma. 159:101-111. 2020
- The effect of intraperitoneal chemotherapy after interval cytoreductive surgery on recurrence and survival in patients with advanced-stage ovarian carcinoma 2020
- Thermodynamic parameters of blood plasma proteins in women with breast tumors 2020
- Executive summary of the American Radium Society (R) Appropriate Use Criteria for management of uterine carcinosarcoma 2020
- Front-line chemo-immunotherapy with carboplatin-paclitaxel using oregovomab indirect immunization in advanced ovarian cancer: A randomized phase II study. 156:523-529. 2020
- A prospective randomized trial of intravenous ketorolac vs. acetaminophen administered with opioid patient-controlled analgesia in gynecologic surgery. 155:468-472. 2019
- Sentinel lymph nodes (SLN) in endometrial cancer: The relationship between primary tumor histology, SLN metastasis size, and non-sentinel node metastasis. 154:53-59. 2019
- Comprehensive genomic profiling of mucinous ovarian carcinoma with comparisons to mucinous colorectal carcinoma 2019
- Comprehensive molecular profiles of low-grade serous ovarian carcinoma 2019
- Differential assessments of blood lipids, lipid peroxidation, antioxidant status, and fatty acids in women with uterine tumors during menopausal period 2019
- Molecular portraits of clear cell ovarian and endometrial carcinoma with comparison to clear cell renal cell carcinoma 2019
- Morpho-structural peculiarities of blood formed elements and clinic-pathological characteristics in women with uterine (Benign, Malignant) tumors in menopausal age 2019
- Post hoc exploratory analysis of rucaparib in patients with platinum-sensitive recurrent ovarian carcinoma from the randomized, placebo-controlled phase III study ARIEL3: Effect of a deleterious germline or no germline BRCA mutation on efficacy 2019
- The effect of age on efficacy and safety outcomes with rucaparib: A post hoc exploratory analysis of ARIEL3, a phase III, randomized, placebo-controlled maintenance study in patients with recurrent ovarian carcinoma 2019
- Timing of postoperative Foley catheter removal fromrobotic-assisted radical hysterectomy in patients with early-stage cervical cancer 2019
- Poster Session Paraaortic lymph node dissection pathology in patients with endometrial cancer undergoing robotic sentinel lymph node mapping (SLNM) 2018
- Recurrence patterns and survival in patients with endometrial cancer undergoing robotic sentinel lymph node mapping (SLNM) 2018
- Sentinel lymph node (SLN) isolated tumor cells (ITCs) in otherwise stage I/II endometrioid endometrial cancer: To treat or not to treat? 2018
- Topacio: Preliminary activity and safety in patients (pts) with platinum-resistant ovarian cancer (PROC) in a phase 1/2 study of niraparib in combination with pembrolizumab 2018
- Sentinel lymph node mapping and staging in endometrial cancer: A Society of Gynecologic Oncology literature review with consensus recommendations 2017
- Patient care needs before and after robotic surgery for gynecologic cases in comparison to laparotomy 2017
- A phase II evaluation of ixabepilone in the treatment of recurrent/persistent carcinosarcoma of the uterus, an NRG Oncology/Gynecologic Oncology Group study. 144:101-106. 2017
- Sentinel lymph node mapping with staging lymphadenectomy for patients with endometrial cancer increases the detection of metastasis. 141:206-210. 2016
- Phase II evaluation of dalantercept, a soluble recombinant activin receptor-like kinase 1 (ALK1) receptor fusion protein, for the treatment of recurrent or persistent endometrial cancer: A An NRG Oncology/Gynecologic Oncology Group Study 0229N. 138:24-29. 2015
- Cervical cancer recurrence risk evaluation based on SUV(max) during initial F-18-FDG PET/CT 2015
- Impact of sentinel lymph node mapping on FIGO stage and GOG risk stratification in early endometrial cancer: A comparative analysis 2015
- Robotic versus Open Type III radical hysterectomy: A multi-institutional experience for early stage cervical cancer 2015
- Robotic transperitoneal infra-renal aortic lymphadenectomy in early-stage endometrial cancer. 136:285-292. 2015
- A prospective study evaluating the clinical relevance of a chemoresponse assay for treatment of patients with persistent or recurrent ovarian cancer. 131:362-367. 2013
- A prospective study evaluating the clinical relevance of a chemoresponse assay for treatment of patients with persistent or recurrent ovarian cancer 2013
- A phase II evaluation of aflibercept in the treatment of recurrent or persistent endometrial cancer: A Gynecologic Oncology Group study (vol 127, pg 538, 2012) 2013
- Phase II trial of combination bevacizumab and temsirolimus in the treatment of A recurrent or persistent endometrial carcinoma: A Gynecologic Oncology Group study. 129:22-27. 2013
- A prospective study of quality of life in patients undergoing pelvic exenteration: Interim results. 128:191-197. 2013
- Analysis of disease recurrence and survival for women with uterine malignancies undergoing robotic surgery. 128:309-315. 2013
- A multicenter evaluation of adjuvant therapy in women with optimally resected stage IIIC endometrial cancer. 128:65-70. 2013
- A phase II evaluation of aflibercept in the treatment of recurrent or persistent endometrial cancer: A Gynecologic Oncology Group study. 127:538-543. 2012
- Does a uterine manipulator affect cervical cancer pathology or identification of lymphovascular space involvement?. 127:98-101. 2012
- Detection of sentinel lymph nodes in patients with endometrial cancer undergoing robotic-assisted staging: A comparison of colorimetric and fluorescence imaging. 126:25-29. 2012
- Short- and long-term morbidity and outcomes after robotic surgery for comprehensive endometrial cancer staging. 125:546-551. 2012
- Longitudinal evaluation of cancer-associated biomarkers before and after weight loss in RENEW study participants: Implications for cancer risk reduction. 125:114-119. 2012
- A multicenter, nonrandomized, open-label, single-arm phase II trial of dovitinib (TKI258) as second-line therapy in patients with fibroblast growth factor receptor 2-mutated or wild-type advanced and/or metastatic endometrial cancer 2012
- An assessment of robotic transperitoneal infra-renal aortic lymphadenectomy in early endometrial carcinoma 2012
- Analysis of recurrence and survival following abdominal radical hysterectomy for cervical cancer in the era of GOG Sedlis criteria 2012
- Detection of sentinel lymph nodes in patients with endometrial cancer undergoing robotic-assisted staging: A comparison of colorimetric and fluorescence imaging 2012
- Endometrial cancer staging in the elderly: Robotic or open? 2012
- Phase II trial of combination bevacizumab and temsirolimus in the treatment of recurrent or persistent endometrial carcinoma: A Gynecologic Oncology Group study 2012
- Pre-clinical models of cellular therapy combined with cytokines demonstrate in vitro and in vivo ovarian cancer cell killing 2012
- Robotic-assisted surgery in gynecologic oncology: A Society of Gynecologic Oncology consensus statement Developed by the Society of Gynecologic Oncology's Clinical Practice Robotics Task Force 2012
- Health-related quality of life outcomes of docetaxel/carboplatin combination therapy vs. sequential therapy with docetaxel then carboplatin in patients with relapsed, platinum-sensitive ovarian cancer: Results from a randomized clinical trial. 123:505-510. 2011
- Tolfenamic acid inhibits ovarian cancer cell growth and decreases the expression of c-Met and survivin through suppressing specificity protein transcription factors. 122:163-170. 2011
- Does a uterine manipulator affect cervical cancer pathology or identification of lymphovascular space involvement? 2011
- Robotic-assisted resection of liver and diaphragm recurrent ovarian carcinoma: Description of technique. 120:419-422. 2011
- Short- and long-term morbidity and outcomes after robotic surgery for endometrial cancer staging 2011
- Survival outcomes for women with uterine malignancy undergoing robot-assisted laparoscopic staging procedures 2011
- A multicenter, randomized, phase II study evaluating the efficacy and safety of combination docetaxel and carboplatin and sequential therapy with docetaxel then carboplatin in patients with recurrent platinum-sensitive ovarian cancer 2010
- Analyses of factors associated with the performance of total abdominal versus robotic-assisted laparoscopic hysterectomy for endometrial cancer 2010
- Biological effects of NVP-BEZ235, an orally available dual P13K/mTOR inhibitor, in human endometrial cancer cell lines in vitro 2010
- PD 0332991, a selective CDK4/6 inhibitor, preferentially inhibits growth of ovarian cancer cells with high Rb and low p16 (CDKN2A) expression 2010
- The role of adjuvant therapy in women with optimally cytoreduced stage IIIC endometrial cancer 2010
- Women with HIV are more commonly infected with non-16 and-18 high-risk HPV types 2010
- Extreme drug resistance assay does not influence survival in women with epithelial ovarian cancer 2010
- Robotic-assisted laparoscopic hysterectomy and lymphadenectomy for endometrial cancer: Analysis of surgical performance. 115:447-452. 2009
- The risk of gastrointestinal perforation and/or fistula in patients with recurrent ovarian cancer receiving bevacizumab compared to standard chemotherapy: A retrospective cohort study. 114:424-426. 2009
- Emergence of robotic assisted surgery in gynecologic oncology: American perspective 2009
- Phase II trial of single agent cetuximab in patients with persistent or recurrent epithelial ovarian or primary peritoneal carcinoma with the potential for dose escalation to rash. 113:21-27. 2009
- The safety and efficacy of day 1 versus day 2 administration of pegfilgrastim in patients receiving myelosuppressive chemotherapy for gynecologic malignancies. 112:601-604. 2009
- Functional characterization of a fluorescent highly tumorigenic cell line to use in an animal model of ovarian cancer 2009
- Robotic assisted laparoscopic hysterectomy with lymphadenectomy for endometrial cancer: The learning curve and beyond 2009
- The use of extreme drug resistance assay in predicting success with intraperitoneal chemotherapy for advanced ovarian cancer 2009
- Tolerability, efficacy and safety of pegylated liposomal doxorubicin in combination with carboplatin versus gemcitabine/carboplatin for the treatment of platinum-sensitive recurrent ovarian cancer: A systematic review 2009
- Synergistic cytotoxicity of interferon alpha-2b and interleukin-2 in combination with PBMC against ovarian cancer: Development of an experimental model for cellular therapy. 112:192-198. 2009
- Robotically assisted laparoscopic hysterectomy versus total abdominal hysterectomy and lymphadenectomy for endometrial cancer. 111:412-417. 2008
- Anti-tumor activity of the TRA-8 anti-DR5 antibody in combination with cisplatin in an ex vivo human cervical cancer model. 108:591-597. 2008
- Colorectal stents for palliation of large-bowel obstructions in recurrent gynecologic cancer: An updated series. 108:482-485. 2008
- Robotically assisted laparoscopic hysterectomy versus total abdominal hysterectomy and lymphadenectomy for endometrial cancer 2008
- Synergistic cytotoxicity of interferon-alpha 2b and interleukin-2 in combination with PBMCs against ovarian cancer: Development of an experimental model for cellular therapy 2008
- Clinical-pathologic and morbidity analyses of types 2 and 3 abdominal radical hysterectomy for cervical cancer. 107:205-210. 2007
- Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and its therapeutic potential in breast and gynecologic cancers 2007
- Clinical-pathologic and morbidity analyses of type 2 and 3 abdominal radical hysterectomy for cervical cancer 2007
- Extended pelvic resection of iliacus muscle and femoral nerve for isolated recurrent uterine cancer. 2007
- Superior pubic rami resection for isolated recurrent uterine cancer. 2007
- Identification of prognostic factors after positive second-look surgery in epithelial ovarian carcinoma. 102:8-14. 2006
- Malignant acanthosis nigricans, tripe palms and the sign of Leser-Tre'lat, a hint to the diagnosis of early stage ovarian cancer: A case report and review of the literature. 101:353-355. 2006
- Two cases of non-Hodgkin's lymphoma presenting as primary gynecologic malignancies. 98:490-492. 2005
- Outcomes of Stage I/II vulvar cancer patients after negative superficial inguinal lymphadenectomy. 98:309-312. 2005
- Endometroid adenocarcinoma of the uterus with cardiac metastasis - A case report and six-year follow-up. 97:256-259. 2005
- Non-Hodgkin's lymphoma presenting as a pelvic mass with elevated CA-125. 94:811-813. 2004
- A phase 11 study to determine the efficacy and tolerability of intravenous ZD9331 in heavily pretreated patients with ovarian cancer. 91:318-325. 2003
- Apoptotic pathways of epothilone BMS 310705. 91:173-178. 2003
- Treatment options for endometrial cancer: experience with topotecan. 90:S28-S33. 2003
- Workshop: options for therapy in ovarian cancer. 90:S45-S50. 2003
- Association between in vitro platinum resistance in the EDR assay and clinical outcomes for ovarian cancer patients. 87:8-16. 2002
- Phase II trial of topotecan and cisplatin in persistent or recurrent squamous and nonsquamous carcinomas of the cervix. 85:89-94. 2002
- Acanthosis Nigricans with endometrial carcinoma: Case report and review of the literature. 84:332-334. 2002
- AN EVALUATION OF GROSHONG CENTRAL VENOUS CATHETERS ON A GYNECOLOGIC ONCOLOGY SERVICE. 56:211-217. 1995
- Intra-abdominal malignancy. 1993
- THE EFFICACY AND SAFETY OF THE CYTOBRUSH DURING PREGNANCY. 44:260-262. 1992
- SURGICAL STAGING OF UTERINE-CANCER - AN ANALYSIS OF PERIOPERATIVE MORBIDITY. 42:209-216. 1991
- IDENTIFICATION OF HUMAN PAPILLOMAVIRUS TYPE-16 IN PRIMARY AND RECURRENT CERVICAL-CANCER FOLLOWING RADIATION-THERAPY. 41:123-128. 1991
- HYSTERECTOMY WITH EXTENDED SURGICAL STAGING AND RADIOTHERAPY VERSUS HYSTERECTOMY ALONE AND RADIOTHERAPY IN STAGE-I ENDOMETRIAL CANCER - A COMPARISON OF COMPLICATION RATES. 36:401-404. 1990
- MELANOSIS OF THE CERVIX. 29:101-104. 1988
- COEXISTENT BREAST AND VAGINAL GRANULOCYTIC SARCOMA. 16:299-304. 1983
Research
category
- OBSTETRICS & GYNECOLOGY Web of Science Category
- ONCOLOGY Web of Science Category
Identity
International Standard Serial Number (ISSN)
- 0090-8258
Electronic International Standard Serial Number (EISSN)
- 1095-6859
Other
journal abbreviation
- GYNECOL ONCOL
- Gynecol Oncol